TrialLeukemia2018
A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS.
Pierre Fenaux et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
79 papers cite itlatest 60 shown
this paperpooled ittrialcites it